How SILASERS Earned US FDA Approval — A MedRegX Case Study
A detailed regulatory success story for a Suresh Indu Lasers Pvt. Ltd..
The Challenge
Suresh Indu Lasers Pvt. Ltd., a growing Indian manufacturer of aesthetic and medical laser systems, had built SILASERS — a Class II laser device used in aesthetic and dermatological procedures — with a strong track record in the domestic market. Entering the United States, however, meant navigating an entirely different regulatory landscape: FDA device classification, Establishment Registration, Device Listing, laser-specific CDRH reporting, and compliance with electrical, mechanical, and biocompatibility safety standards. With no prior in-house US regulatory experience, the company risked costly delays, documentation rejections, or being blocked from the US market altogether.
Our Solution
MedRegX took ownership of the complete FDA registration pathway for SILASERS — from device classification and product code confirmation through to Establishment Registration and Device Listing submission. Our regulatory team compiled and verified technical documentation, coordinated laser safety compliance under CDRH requirements, reviewed labeling against 21 CFR Part 801, aligned Quality System documentation with 21 CFR Part 820, and managed US Agent coordination and FDA correspondence throughout.
Final Result
SILASERS received successful US FDA Establishment Registration and Device Listing, clearing the primary regulatory barrier to market entry. Suresh Indu Lasers Pvt. Ltd. is now positioned to legally market and export SILASERS to US-based distributors and clinics, opening a high-value international revenue channel.
Detailed Implementation
The US Market Is the Prize — and the Hardest Door to Open
The United States is the largest aesthetic device market in the world. It's also the most tightly regulated. For Suresh Indu Lasers Pvt. Ltd., a manufacturer that had already proven SILASERS' performance across domestic and regional markets, US entry meant clearing an entirely different bar — one set by the FDA's Center for Devices and Radiological Health (CDRH).
No US regulatory footprint. No prior FDA submission history. One shot to get classification, documentation, and safety compliance right the first time.
Two Compliance Systems. One Device.
SILASERS didn't just need medical device clearance — it needed to satisfy laser-specific regulation too. That meant clearing requirements across:
Device Classification — correct FDA product code based on intended use, energy output, and clinical application
Laser Safety (IEC 60825-1) — CDRH's laser product performance standards
Electrical & Mechanical Safety (IEC 60601) — general medical device compliance
Labeling (21 CFR Part 801) — warnings, intended use claims, technical specs
Quality System Alignment (21 CFR Part 820) — design controls & manufacturing documentation
One misstep in classification alone can restart a submission months into the process. This is where most first-time applicants lose the most time.
How MedRegX Ran the Registration
We didn't treat this as a single filing. We ran it as a structured, milestone-based project:
1. Classification First, Always Our regulatory team assessed SILASERS' technical specs and clinical use to lock in the correct FDA product code before anything else moved forward — preventing the misclassification trap that derails most first-time filings.
2. Documentation, Verified Line by Line Existing electrical, mechanical, and laser output test reports were cross-checked against CDRH and FDA expectations. Gaps were flagged and closed before submission — not discovered after.
3. Labeling Built for US Standards Every warning, intended-use claim, and laser classification label was reviewed against 21 CFR Part 801 — a step that trips up even experienced manufacturers entering the US for the first time.
4. US Agent Coordination, Handled We managed the mandatory US Agent relationship and ensured Establishment Registration and Device Listing data was submitted accurately and consistently across every touchpoint.
5. Direct FDA Correspondence Every query, every clarification request — handled promptly and directly with FDA on the client's behalf, compressing the timeline well below the industry norm for first-time applicants.
The Result
SILASERS is now FDA-registered and listed — cleared to be legally marketed and distributed across the United States.
That's not just a regulatory checkbox. It's access to the single largest aesthetic device market in the world, and a foundation Suresh Indu Lasers can now replicate for every future product line entering the US.
The Bigger Lesson
Great engineering doesn't guarantee market access. Regulatory strategy does.
Classification accuracy, airtight documentation, and proactive agency communication are what separate a smooth market entry from a stalled one. For manufacturers with US ambitions, the right regulatory partner isn't a formality — it's the fastest path to revenue. Connect With MedRegX for your US FDA APPROVAL